Connect with us

U.S. trade negotiator discusses COVID-19 IP waiver with Moderna CEO

HBS Reporting

U.S. trade negotiator discusses COVID-19 IP waiver with Moderna CEO

U.S. trade negotiator discusses COVID-19 IP waiver with Moderna CEO

U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna (MRNA.O) to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai’s office said.

Tai and Moderna Chief Executive Stephane Bancel also discussed increasing vaccine production and global health issues, Tai’s office said in a statement.

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in HBS Reporting

To Top
Translate »